We test a multiple panel and send it to an outside vendor.

 

Best Wishes, Stay Safe, and May you Prosper,

 

Julie A. Eisenhauer BSN, RN

Employee Health Nurse

Tuba City Regional Health Care Corporation

Human Resources/Employee Health

PO Box 600

Tuba City, AZ. 86045

Direct Ph#: (928)283-1511

Or, Mitel 45111

Julie.eisenhauer@tchealth.org

 

From: MCOH-EH <mcoh-eh-bounces@mylist.net> On Behalf Of Olson, Amy via MCOH-EH
Sent: Monday, December 9, 2024 8:48 AM
To: MCOH-EH <mcoh-eh@mylist.net>
Cc: Olson, Amy <aolson3@phoenixchildrens.com>
Subject: Re: [MCOH-EH] [EXTERNAL] UDS for diversion investigation

 

Caution: This email originated from outside of the organization. Do not click links or open attachments unless you recognize the sender and know the content is safe.



We test a multiple panel.

 

Amy Olson COHN-S, MS, RN

Director- Occupational Health

 


1919 E. Thomas Rd. Phoenix, AZ 85016

aolson3@phoenixchildrens.com

(602) 933-5647

 

 

 

From: MCOH-EH <mcoh-eh-bounces@mylist.net> On Behalf Of Higazi, Patricia via MCOH-EH
Sent: Monday, December 2, 2024 10:49 AM
To: MCOH-EH <mcoh-eh@mylist.net>
Cc: Higazi, Patricia <Patricia.Higazi@chkd.org>
Subject: [EXTERNAL] [MCOH-EH] UDS for diversion investigation

 

When investigating a potential diversion of a schedule 1 drug do you all include a multiple panel UDS for legal and illegal drugs, or just test for the drug being investigated? Patricia Higazi MSN RN COHN Occupational Health Director Children's

 

**WARNING** DO NOT CLICK links or attachments unless you recognize the sender: prvs=00733f3a3d=mcoh-eh-bounces@mylist.net.

When investigating a potential diversion of a schedule 1 drug do you all include a multiple panel UDS for legal and illegal drugs, or just test for the drug being investigated?

 

 

Patricia Higazi MSN RN COHN

Occupational Health Director

Children's Hospital of The King's Daughters

Norfolk, Virginia

Tel: 757 668 7491

Fax: (757) 668 8775

Email: patricia.higazi@chkd.org

 

This transmission, including any attachments, is for the sole use of the intended recipient(s) and may contain information that is confidential, proprietary, legally privileged, or otherwise protected by law from disclosure. Any unauthorized review, use, copying, disclosure, or distribution is prohibited. If you are not the intended recipient, or the person responsible for delivering this to an addressee, you should notify the sender immediately by telephone or by reply e-mail, and destroy all copies of the original message.

 

CONFIDENTIALITY NOTICE: This e-mail communication and any attachments may contain confidential and privileged information for the use of the designated recipients. If you are not the intended recipient, (or authorized to receive for the recipient) you are hereby notified that you have received this communication in error and that any review, disclosure, dissemination, distribution or copying of it or its contents is prohibited. If you have received this communication in error, please destroy all copies of this communication and any attachments and contact the sender by reply e-mail or telephone.